Defining antibiotic resistance-towards international harmonization
Open Access
- 16 May 2014
- journal article
- review article
- Published by Uppsala Medical Society in Upsala Journal of Medical Sciences
- Vol. 119 (2) , 78-86
Abstract
Antimicrobial susceptibility testing with phenotypic methods requires breakpoints, i.e. a minimum inhibitory concentration (MIC) categorizing micro-organisms into susceptible, intermediately susceptible, and resistant for the relevant antimicrobial agent. Determinations of breakpoints require tools such as the understanding of dosing, MIC distributions of organisms without resistance mechanisms, pharmacokinetics, pharmacodynamics, and of clinical outcome in defined clinical situations. Several European countries (France, Germany, Norway, Sweden, the Netherlands, and UK), have national breakpoint committees, often with 20-30 years of experience and tradition. These committees now co-operate under the umbrella of the European Committee on Antimicrobial Susceptibility Testing (EUCAST), organized by The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Centre for Disease Prevention and Control (ECDC). Together with the European Medicines Agency (EMA), EUCAST determines breakpoints for existing and new antibacterial and antifungal agents. Moreover, EUCAST has developed a disk diffusion antimicrobial susceptibility testing method which is now, together with the new European breakpoints, being implemented in many countries both inside and outside Europe.Keywords
This publication has 8 references indexed in Scilit:
- Validation of EUCAST zone diameter breakpoints against reference broth microdilutionClinical Microbiology and Infection, 2014
- Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratoriesClinical Microbiology and Infection, 2014
- EUCAST expert rules in antimicrobial susceptibility testingClinical Microbiology and Infection, 2013
- The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approachClinical Microbiology and Infection, 2012
- Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off valuesClinical Microbiology and Infection, 2006
- European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteriaJournal of Antimicrobial Chemotherapy, 2003
- Antibiotic sensitivity testing. Report of an international collaborative study.1971
- Single-Disk Antibiotic-Sensitivity Testing of StaphylococciA.M.A. Archives of Internal Medicine, 1959